NCBI PubMed Central
open access
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Optimization and Application of CRISPR/Cas-based in planta Gene Targeting Technologies / Seda Yaşar ; Holger Puchta, Peter Nick#1052387
- Crispr enzyme mutations reducing off-target effects — The Broad Institute, Inc. (US20250179453A1)#607484
- A “Bare Hope of A Result”: The Second CRISPR Patent Appeal#333966
- Delivery, use and therapeutic applications of the crispr-cas systems and … — The Broad Institute, Inc. (US20250381297A1)#607482
- CRISPR having or associated with destabilization domains — The Broad Institute, Inc. (US12435320B2)#607480
Record · ID 308890
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive